EMJ Rheumatology 8 [Supplement 3] . 2021

In this issue

PSORIATIC arthritis (PsA) is a chronic form of immune-mediated arthritis that typically presents through a range of clinical symptoms, including joint inflammation, peripheral joint disease, and psoriasis. The use of biologic agents to treat this condition has proven effective in recent years, with several clinical trials currently assessing these treatments. This research was presented across a series of symposium, poster, and abstract sessions, which took place from 2nd to 5th June 2021 at the European e-Congress of Rheumatology meeting of the European League Against Rheumatism (EULAR) virtual congress.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given